Table 3.
Landmark Overall Survival GBM at First or Second Recurrence Toca 511 and Toca FC vs. Lomustine External Control
Treatment Group | Toca 511&Toca FC (N=27) |
Lomustine (N=84) |
p-value |
---|---|---|---|
Landmark OS Rate | |||
OS6 | 96.0% | 61.8% | <0.001 |
OS9 | 83.5% | 38.4% | <0.001 |
OS12 | 54.8% | 26.4% | 0.017 |
OS24 | 29.1% | 9.1% | 0.065 |